Wilmington, Delaware, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, "Breast Lesion Localization Methods Market by Localization Methods (Wire Localization, Radioisotope Localization, Magnetic Tracers’ Localization and Other), by Technology (Mammography-Guided Localization and Ultrasound-Guided Localization), Lesion Type (Non-Palpable Lesions and Palpable Lesions), and End User (Specialty Clinics, Hospitals, Diagnostic Centers and Other): Global Opportunity Analysis and Industry Forecast, 2024-2033". According to the report, the breast lesion localization methods market was valued at $1.2 billion in 2023, and is estimated to reach $3.6 billion by 2033, growing at a CAGR of 11.7% from 2024 to 2033.
Request Sample of the Report on Breast Lesion Localization Methods Market 2033 - https://www.alliedmarketresearch.com/request-sample/A324384
Prime Determinants of Growth
The breast lesion localization methods market is primarily driven by the increasing prevalence of breast cancer, rise in awareness about the early diagnosis of breast cancer, and technological advancement in breast lesion localization methods. Rising incidences of breast cancer globally have heightened the demand for breast lesion localization methods. With breast cancer being one of the most prevalent cancers among women worldwide, healthcare systems are under pressure to expand screening programs to meet diagnostic needs effectively. In addition, increasing awareness among women about the importance of early detection plays a crucial role. Public health campaigns and initiatives by healthcare organizations globally have raised awareness levels, encouraging more women to undergo regular screening tests. Furthermore, technological innovations in localization devices, including wire-guided localization systems, radioactive seed localization (RSL), and magnetic tracers, have improved procedural outcomes by offering greater precision and reduced invasiveness. Furthermore, the shift towards minimally invasive procedures in breast surgery has spurred the development of innovative localization techniques that enhance patient comfort and recovery times.
Report Coverage & Details
Repot Coverage | Details |
Forecast Period | 2024–2033 |
Base Year | 2023 |
Market Size in 2023 | $1.2 billion |
Market Size in 2033 | $3.6 billion |
CAGR | 11.7% |
No. of Pages in Report | 280 |
Segments Covered | Localization Methods, Technology, Lesion Type, End User and Region |
Drivers |
|
Opportunities |
|
Restraint |
|
Want to Explore More, Connect to our Analyst - https://www.alliedmarketresearch.com/connect-to-analyst/A324384
Segment Highlights
The magnetic tracers’ localization segment dominated market share in 2023
By localization methods, magnetic tracers’ localization dominated the market share in 2023. This is attributed to the technological advancements that have improved accuracy and efficiency in locating breast lesions. Magnetic tracers utilize magnetic fields to guide surgeons to the precise location of abnormalities within the breast tissue, offering a non-radioactive and potentially more reliable alternative to radioisotope localization.
Ultrasound-guided localization segment dominated the market share in 2023
By technology, ultrasound-guided localization segment dominated the market share in 2023. This is attributed to the fact that ultrasound-guided localization offers several advantages over mammography-guided localization, including real-time imaging capabilities that provide clearer visibility of breast lesions, especially in dense breast tissue. This technology is also preferred for its non-ionizing radiation, making it safer for repeated procedures. Additionally, advancements in ultrasound technology have enhanced its accuracy and precision in guiding localization procedures, thereby increasing its adoption among healthcare providers.
Non-palpable lesions segment dominated the market share in 2023
By lesion type, non-palpable lesions segment dominated the market share in 2023. This is attributed to the fact that advancements in imaging technologies, such as digital mammography, ultrasound, and MRI, have significantly improved the detection and diagnosis of non-palpable lesions. These lesions are often detected at earlier stages, increasing the demand for precise localization methods to guide biopsy and surgical procedures accurately.
Hospital segment dominated market share in 2023
By end user, hospital segment dominated the market share in 2023. This is attributed to the fact that hospitals typically serve as the primary centers for diagnosing and treating breast cancer, making them pivotal in the adoption of breast lesion localization methods. Hospitals possess the infrastructure, specialized equipment, and trained medical personnel necessary to perform these procedures effectively. They also often have established oncology departments where multidisciplinary teams collaborate to provide comprehensive care for breast cancer patients. This comprehensive approach includes the use of advanced imaging technologies, such as mammography and ultrasound, which complement lesion localization methods by accurately identifying and characterizing breast lesions.
Regional Outlook
North America holds a dominant position in the market, attributed to high prevalence of breast cancer, strong presence of major key players and well-established healthcare infrastructure. However, Asia-Pacific region is expected to register highest CAGR in the forecast period. This is attributed to expanding healthcare infrastructure, rising healthcare expenditure in countries like China, India, and Japan and rise in prevalence of the breast cancer.
For Purchase Related Queries/Inquiry - https://www.alliedmarketresearch.com/purchase-enquiry/A324384
Key Players
- Becton Dickinson and Company
- Hologic Inc.
- Cook Group
- Merit Medical
- Sterylabs, C.R.
- Bard, Inc.
- Leica Biosystems
- Argon Medical Device
- Endomagnetics
- Cianna Medical
The report provides a detailed analysis of these key players in the global breast lesion localization methods market. These players have adopted different strategies such as product launch and product approval to increase their market share and maintain dominant shares in different regions. The report is valuable in highlighting business performance, operating segments, product portfolio, and strategic moves of market players to showcase the competitive scenario.
Recent Development
- August 2022: MOLLI Surgical and Sunnybrook Health Sciences Centre announced the launch of Molli, a wire-free and radiation-free technology for localizing lesions for breast surgery.
- April 2022: Merit Medical Systems, Inc. announced that U.S. Food and Drug Administration approved its SCOUT Bx Delivery System, which according to the company is the first wire-free breast localization solution that can be deployed at the time of stereotactic or MRI-guided biopsy.
Trending Reports in Healthcare Industry:
Viscosupplementation Market - Global Opportunity Analysis and Industry Forecast, 2023-2032
Healthcare CRM Market - Global Opportunity Analysis and Industry Forecast, 2023-2032
Personal Mobility Devices Market - Global Opportunity Analysis and Industry Forecast, 2023-2032
Drug Delivery Devices Market - Global Opportunity Analysis and Industry Forecast, 2023-2032
AVENUE- A Subscription-Based Library (Premium on-demand, subscription-based pricing model) Offered by Allied Market Research:
AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.
Get an access to the library of reports at any time from any device and anywhere. For more details, follow the link: https://www.alliedmarketresearch.com/library-access
About Allied Market Research:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact
David Correa
1209 Orange Street,
Corporation Trust Center,
Wilmington, New Castle,
Delaware 19801 USA.
Toll Free: +1-800-792-5285
Int’l: +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
Web: https://www.alliedmarketresearch.com
Follow Us on: LinkedIn Twitter